SK Biopharmaceuticals signs epilepsy drug licensing deal with Biohaven
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
EUR/USD Price Forecast: Remains sideways ahead of key US events
The Euro (EUR) continues to trade in a tight range at around 1.1660 against the US Dollar (USD) during the Asian trading session on Wednesday.
Sanctions without exit strategies are fracturing the global economy
Wars in the 21st century aren’t fought only with missiles and soldiers anymore. Increasingly, they’re fought through banking systems, shipping lanes, semiconductor controls and currency clearing…
Hy-Tech Engineers IPO Day 3: GMP at 57%, subscription reaches 19.33x. Should you subscribe?
The Hy-Tech Engineers IPO entered its third day of bidding on August 26, with the issue subscribed 19.33 times by the end of Day 2.
Opportunity to raise money via NFOs maybe limited: Chirag Setalvad, HDFC AMC
The slowdown in NFOs is more to do with the product suite being complete rather than concerns on the market's trajectory, Setalvad said.